Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Acchiardo

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Archives of Neurology|June 1, 1981
Procainamide-induced myasthenia-like weakness in a patient with peripheral neuropathyE Niakan, T E Bertorini, S R Acchiardo, et al.
Clinical Pharmacology and Therapeutics|August 1, 1975
Folic acid dosage for chronic hemodialysis patientsV A Skoutakis, S R Acchiardo, M C Meyer, et al.
ASAIO Transactions|July 1, 1991
Is hematologic response to iron and erythropoietin in hemodialysis patients affected by other factors?S R Acchiardo, L W Moore, J A Sargent, et al.
The American Surgeon|June 1, 1976
Arteriovenous fistulas for hemodialysis: experience with 100 casesR C Cheek, J J Messina, S R Acchiardo, et al.
Journal of the American Dietetic Association|January 1, 1987
Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patientsD K Bannister, S R Acchiardo, L W Moore, et al.
ASAIO Transactions|July 1, 1989
Are high flux dialysis and erythropoietin treatment in a collision course?S R Acchiardo, B P Quinn, L B Burk, et al.
Clinical Nephrology|June 5, 2007
Dialysis catheter-induced superior vena cava syndrome and downhill esophageal varicesM W Greenwell, S L Basye, S S Dhawan, et al.
Pharmacotherapy|January 1, 1991
The efficacy of nutrition support in infected patients with chronic renal failureK L Vehe, R O Brown, L W Moore, et al.
American Journal of Hospital Pharmacy|January 1, 1978
Role-effectiveness of the pharmacist in the treatment of hemodialysis patientsV A Skoutakis, S R Acchiardo, D R Martinez, et al.
The American Journal of the Medical Sciences|April 4, 2000
Biphasic changes in nitric oxide generation in hemodialyzed patients with end-stage renal disease treated with recombinant human erythropoietinE S Kang, Y B Wang, R Cardenas, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Archives of Neurology|June 1, 1981
Procainamide-induced myasthenia-like weakness in a patient with peripheral neuropathyE Niakan, T E Bertorini, S R Acchiardo, et al.
Clinical Pharmacology and Therapeutics|August 1, 1975
Folic acid dosage for chronic hemodialysis patientsV A Skoutakis, S R Acchiardo, M C Meyer, et al.
ASAIO Transactions|July 1, 1991
Is hematologic response to iron and erythropoietin in hemodialysis patients affected by other factors?S R Acchiardo, L W Moore, J A Sargent, et al.
The American Surgeon|June 1, 1976
Arteriovenous fistulas for hemodialysis: experience with 100 casesR C Cheek, J J Messina, S R Acchiardo, et al.
Journal of the American Dietetic Association|January 1, 1987
Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patientsD K Bannister, S R Acchiardo, L W Moore, et al.
ASAIO Transactions|July 1, 1989
Are high flux dialysis and erythropoietin treatment in a collision course?S R Acchiardo, B P Quinn, L B Burk, et al.
Clinical Nephrology|June 5, 2007
Dialysis catheter-induced superior vena cava syndrome and downhill esophageal varicesM W Greenwell, S L Basye, S S Dhawan, et al.
Pharmacotherapy|January 1, 1991
The efficacy of nutrition support in infected patients with chronic renal failureK L Vehe, R O Brown, L W Moore, et al.
American Journal of Hospital Pharmacy|January 1, 1978
Role-effectiveness of the pharmacist in the treatment of hemodialysis patientsV A Skoutakis, S R Acchiardo, D R Martinez, et al.
The American Journal of the Medical Sciences|April 4, 2000
Biphasic changes in nitric oxide generation in hemodialyzed patients with end-stage renal disease treated with recombinant human erythropoietinE S Kang, Y B Wang, R Cardenas, et al.
Pageof 5